Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Rapid development of HIV elite control in a patient with acute infection.

Morley D, Lambert JS, Hogan LE, De Gascun C, Redmond N, Rutishauser RL, Thanh C, Gibson EA, Hobbs K, Bakkour S, Busch MP, Farrell J, McGetrick P, Henrich TJ.

BMC Infect Dis. 2019 Sep 18;19(1):815. doi: 10.1186/s12879-019-4374-8.

2.

Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.

Crowley D, Cullen W, Lambert JS, Van Hout MC.

PLoS One. 2019 Sep 11;14(9):e0222186. doi: 10.1371/journal.pone.0222186. eCollection 2019.

3.

Hepatitis C virus infection in Irish drug users and prisoners - a scoping review.

Crowley D, Murtagh R, Cullen W, Lambert JS, McHugh T, Van Hout MC.

BMC Infect Dis. 2019 Aug 8;19(1):702. doi: 10.1186/s12879-019-4218-6.

4.

Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.

Crowley D, Murtagh R, Cullen W, Keevans M, Laird E, McHugh T, McKiernan S, Miggin SJ, O'Connor E, O'Reilly D, Betts-Symonds G, Tobin C, Van Hout MC, Lambert JS.

Harm Reduct J. 2019 Jul 5;16(1):42. doi: 10.1186/s12954-019-0313-7.

5.

Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.

Crowley D, Van Hout MC, Murphy C, Kelly E, Lambert JS, Cullen W.

BMC Nurs. 2019 Jun 13;18:23. doi: 10.1186/s12912-019-0347-x. eCollection 2019.

6.

Single Core Genome Sequencing for Detection of both Borrelia burgdorferi Sensu Lato and Relapsing Fever Borrelia Species.

Lee SH, Healy JE, Lambert JS.

Int J Environ Res Public Health. 2019 May 20;16(10). pii: E1779. doi: 10.3390/ijerph16101779.

7.

Factors affecting lifetime reproduction, long-term territory-specific reproduction, and estimation of habitat quality in northern goshawks.

Reynolds RT, Lambert JS, Kay SL, Sanderlin JS, Bird BJ.

PLoS One. 2019 May 22;14(5):e0215841. doi: 10.1371/journal.pone.0215841. eCollection 2019.

8.

Metagenomic 16S rRNA gene sequencing survey of Borrelia species in Irish samples of Ixodes ricinus ticks.

Lambert JS, Cook MJ, Healy JE, Murtagh R, Avramovic G, Lee SH.

PLoS One. 2019 Apr 15;14(4):e0209881. doi: 10.1371/journal.pone.0209881. eCollection 2019.

9.

The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.

Crowley D, Lambert JS, Betts-Symonds G, Cullen W, Keevans M, Kelly E, Laird E, McHugh T, McKiernan S, Miggin SJ, Murphy C, Murtagh R, O'Reilly D, Tobin C, Van Hout MC.

Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800369.

10.

'HepCheck Dublin': an intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care.

Lambert JS, Murtagh R, Menezes D, O'Carroll A, Murphy C, Cullen W, McHugh T, Avramovic G, Tinago W, Van Hout MC.

BMC Infect Dis. 2019 Feb 7;19(1):128. doi: 10.1186/s12879-019-3748-2.

11.

Therapeutic drug monitoring of darunavir/ritonavir in pregnancy.

Murtagh R, Else LJ, Kuan KB, Khoo SH, Jackson V, Patel A, Lawler M, McDonald G, Le Blanc D, Avramovic G, Redmond N, Lambert JS.

Antivir Ther. 2019;24(3):229-233. doi: 10.3851/IMP3291.

PMID:
30728322
12.

Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.

Crowley D, Van Hout MC, Murphy C, Kelly E, Lambert JS, Cullen W.

Health Justice. 2018 Dec 19;6(1):23. doi: 10.1186/s40352-018-0081-6.

13.

Hepatitis C Prevalence and Management Among Patients Receiving Opioid Substitution Treatment in General Practice in Ireland: Baseline Data from a Feasibility Study.

Murtagh R, Swan D, O'Connor E, McCombe G, Lambert JS, Avramovic G, Cullen W.

Interact J Med Res. 2018 Dec 19;7(2):e10313. doi: 10.2196/10313.

14.

Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.

Crowley D, Van Hout MC, Lambert JS, Kelly E, Murphy C, Cullen W.

Harm Reduct J. 2018 Dec 11;15(1):62. doi: 10.1186/s12954-018-0269-z.

15.

Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care.

McCombe G, Swan D, O'Connor E, Avramovic G, Vickerman P, Ward Z, Surey J, Macías J, Lambert JS, Cullen W.

JMIR Res Protoc. 2018 Jun 4;7(6):e149. doi: 10.2196/resprot.9043.

16.

Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol.

Swan D, Cullen W, Macias J, Oprea C, Story A, Surey J, Vickerman P, Lambert JS.

Expert Rev Gastroenterol Hepatol. 2018 Mar;12(3):303-314. doi: 10.1080/17474124.2018.1424541. Epub 2018 Jan 16.

PMID:
29300496
17.

Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.

Crowley D, Cullen W, Laird E, Lambert JS, Mc Hugh T, Murphy C, Van Hout MC.

J Transl Int Med. 2017 Jun 30;5(2):112-119. doi: 10.1515/jtim-2017-0017. eCollection 2017 Jun.

18.

The HIV Care Cascade and sub-analysis of those linked to but not retained in care: the experience from a tertiary HIV referral service in Dublin Ireland.

McGettrick P, Ghavami-Kia B, Tinago W, Macken A, O'Halloran J, Lambert JS, Sheehan G, Mallon PWG.

HIV Clin Trials. 2017 May;18(3):93-99. doi: 10.1080/15284336.2017.1298317. Epub 2017 Mar 14.

PMID:
28290773
19.

Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.

Gray E, O'Leary A, Bergin C, Cannon M, Courtney G, Crosbie O, De Gascun CF, Fanning LJ, Feeney E, Houlihan DD, Kelleher B, Lambert JS, Lee J, Mallon P, McConkey S, McCormick A, McKiernan S, McNally C, Murray F, Sheehan G, Stewart S, Walsh C, Norris S; Irish Hepatitis C Outcomes and Research Network (ICORN).

Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):593-601. doi: 10.1080/17474124.2017.1292850. Epub 2017 Feb 22. Erratum in: Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):viii.

PMID:
28276815
20.

Experience of dolutegravir in HIV-infected treatment-naive patients from a tertiary care University Hospital in Ireland.

Waqas S, O'Connor M, Levey C, Mallon P, Sheehan G, Patel A, Avramovic G, Lambert JS.

SAGE Open Med. 2016 Oct 25;4:2050312116675813. eCollection 2016.

21.

Feasibility of alcohol screening among patients receiving opioid treatment in primary care.

Henihan AM, McCombe G, Klimas J, Swan D, Leahy D, Anderson R, Bury G, Dunne CP, Keenan E, Lambert JS, Meagher D, O'Gorman C, O'Toole TP, Saunders J, Shorter GW, Smyth BP, Kaner E, Cullen W.

BMC Fam Pract. 2016 Nov 5;17(1):153.

22.

Commentary on Zeremski et al. (2016): Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention.

McCombe G, Leahy D, Klimas J, Lambert JS, Cullen W, Henihan AM.

J Addict Med. 2016 Sep-Oct;10(5):363-4. doi: 10.1097/ADM.0000000000000244. No abstract available.

PMID:
27685682
23.

High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme.

Gray E, O'Leary A, Stewart S, Bergin C, Cannon M, Courtney G, Crosbie O, De Gascun CF, Fanning LJ, Feeney E, Houlihan DD, Kelleher B, Lambert JS, Lee J, Mallon P, McConkey S, McCormick A, McKiernan S, McNally C, Murray F, Sheehan G, Norris S; Irish Hepatitis C Outcomes and Research Network (ICORN).

J Hepatol. 2016 Aug;65(2):446-8. doi: 10.1016/j.jhep.2016.03.022. Epub 2016 Apr 27. No abstract available.

PMID:
27130842
24.

Lamivudine Monotherapy: Experience of Medium-term Outcomes in HIV-infected Children Unable to Adhere to Triple Therapy.

Linder V, Goldswain C, Adler H, Carty C, Harper K, Jackson V, Lambert JS, Boon G.

Pediatr Infect Dis J. 2016 Jul;35(7):e199-205. doi: 10.1097/INF.0000000000001156.

PMID:
27031256
25.

Screening for asymptomatic urogenital Chlamydia trachomatis infection at a large Dublin maternity hospital: results of a pilot study.

O'Higgins AC, Jackson V, Lawless M, Le Blanc D, Connolly G, Drew R, Eogan M, Lambert JS.

Ir J Med Sci. 2017 May;186(2):393-397. doi: 10.1007/s11845-016-1429-3. Epub 2016 Mar 11.

PMID:
26969456
26.

The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection.

O'Halloran JA, Dunne E, Gurwith M, Lambert JS, Sheehan GJ, Feeney ER, Pozniak A, Reiss P, Kenny D, Mallon P.

HIV Med. 2015 Nov;16(10):608-19. doi: 10.1111/hiv.12270. Epub 2015 Jun 25.

27.

Impaired glucose metabolism in HIV-infected pregnant women: a retrospective analysis.

Moore R, Adler H, Jackson V, Lawless M, Byrne M, Eogan M, Lambert JS.

Int J STD AIDS. 2016 Jun;27(7):581-5. doi: 10.1177/0956462415587625. Epub 2015 May 20.

PMID:
25999164
28.

Syphilis serology in pregnancy: an eight-year study (2005-2012) in a large teaching maternity hospital in Dublin, Ireland.

McGettrick P, Ferguson W, Jackson V, Eogan M, Lawless M, Ciprike V, Varughese A, Coulter-Smith S, Lambert JS.

Int J STD AIDS. 2016 Mar;27(3):226-30. doi: 10.1177/0956462415580226. Epub 2015 Mar 30.

PMID:
25829517
29.

Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads.

Jackson V, Ferguson W, Kelleher TB, Lawless M, Eogan M, Nusgen U, Coughlan S, Connell J, Lambert JS.

Eur J Clin Microbiol Infect Dis. 2015 Mar;34(3):619-23. doi: 10.1007/s10096-014-2270-0. Epub 2014 Nov 9.

PMID:
25381607
30.

Daclatasvir for the treatment of hepatitis C virus infection.

Adler H, Lambert JS.

Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):725-38. doi: 10.1586/17474124.2014.925798. Epub 2014 May 31. Review.

PMID:
24882552
31.

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

Else LJ, Jackson V, Brennan M, Back DJ, Khoo SH, Coulter-Smith S, Lambert JS.

HIV Med. 2014 Nov;15(10):604-10. doi: 10.1111/hiv.12164. Epub 2014 May 14.

32.

Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets.

Tinago W, Coghlan E, Macken A, McAndrews J, Doak B, Prior-Fuller C, Lambert JS, Sheehan GJ, Mallon PW; Mater Immunology Study Group.

PLoS One. 2014 May 9;9(5):e97011. doi: 10.1371/journal.pone.0097011. eCollection 2014.

33.

Clinical focus: infections in pregnancy.

Adler H, Lambert JS.

Hosp Pract (1995). 2014 Apr;42(2):108-24. doi: 10.3810/hp.2014.04.1109. Review.

PMID:
24769790
34.

Symptomatic primary Cytomegalovirus infection in a HIV-positive pregnant woman.

Bergin S, Ferguson W, Corcoran S, Varughese A, Byrne D, Lawless M, Eogan M, Lambert JS.

Int J STD AIDS. 2014 Dec;25(14):1041-3. doi: 10.1177/0956462414528314. Epub 2014 Mar 19.

PMID:
24648317
35.

Management of ganciclovir-resistant cytomegalovirus retinitis in HIV infection in the era of antiretroviral therapy.

Adler H, De Gascun CF, McSweeney F, Acheson RW, Brannigan ET, Duffy M, Keegan DJ, Lambert JS.

Int J STD AIDS. 2014 Oct;25(11):827-9. doi: 10.1177/0956462414522773. Epub 2014 Feb 10.

PMID:
24516078
36.

Investigation into the reasons for maternal default from HIV care postpartum: a 3-year retrospective review.

Lambert JS, Avramovic G, Jackson V, Sammon N, Lally S, Campbell FJ.

AIDS Patient Care STDS. 2014 Jan;28(1):1-3. doi: 10.1089/apc.2013.0267. Epub 2013 Dec 31. No abstract available.

PMID:
24380437
37.

Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.

Tinago W, O'Halloran JA, O'Halloran RM, Macken A, Lambert JS, Sheehan GJ, Mallon PW.

HIV Med. 2014 Apr;15(4):224-32. doi: 10.1111/hiv.12107. Epub 2013 Nov 12.

38.

Seroprevalence of Schistosomiasis and Strongyloides infection in HIV-infected patients from endemic areas attending a European infectious diseases clinic.

Sadlier CM, Brown A, Lambert JS, Sheehan G, Mallon PW.

AIDS Res Ther. 2013 Sep 8;10(1):23. doi: 10.1186/1742-6405-10-23.

39.

Hepatitis C virus-associated thrombocytopenia in pregnancy: impact upon multidisciplinary care provision.

Monteith C, Ní Áinle F, Cooley S, Lambert JS, Kelleher B, Jackson V, Eogan M.

J Perinat Med. 2014 Jan;42(1):135-8. doi: 10.1515/jpm-2013-0080.

PMID:
24006316
40.

The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation.

Feeney ER, McAuley N, O'Halloran JA, Rock C, Low J, Satchell CS, Lambert JS, Sheehan GJ, Mallon PW.

J Infect Dis. 2013 Feb 15;207(4):628-37. doi: 10.1093/infdis/jis723. Epub 2012 Nov 29.

PMID:
23204179
41.

Zebrafish globin switching occurs in two developmental stages and is controlled by the LCR.

Ganis JJ, Hsia N, Trompouki E, de Jong JL, DiBiase A, Lambert JS, Jia Z, Sabo PJ, Weaver M, Sandstrom R, Stamatoyannopoulos JA, Zhou Y, Zon LI.

Dev Biol. 2012 Jun 15;366(2):185-94. doi: 10.1016/j.ydbio.2012.03.021. Epub 2012 Apr 19.

42.

Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy.

Satchell CS, O'Halloran JA, Cotter AG, Peace AJ, O'Connor EF, Tedesco AF, Feeney ER, Lambert JS, Sheehan GJ, Kenny D, Mallon PW.

J Infect Dis. 2011 Oct 15;204(8):1202-10. doi: 10.1093/infdis/jir509.

PMID:
21917893
43.

Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection.

O'Halloran JA, De Gascun CF, Dunford L, Carr MJ, Connell J, Howard R, Hall WW, Lambert JS.

J Clin Virol. 2011 Oct;52(2):151-4. doi: 10.1016/j.jcv.2011.06.020. Epub 2011 Jul 28. No abstract available.

PMID:
21802353
44.

Utility of therapeutic drug monitoring in the management of HIV-infected pregnant women in receipt of lopinavir.

Caswell RJ, Phillips D, Chaponda M, Khoo SH, Taylor GP, Ghanem M, Poulton M, Welch J, Gibbons S, Jackson V, Lambert JS.

Int J STD AIDS. 2011 Jan;22(1):11-4. doi: 10.1258/ijsa.2009.009184.

45.

Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy.

Lambert JS, Else LJ, Jackson V, Breiden J, Gibbons S, Dickinson L, Back DJ, Brennan M, Connor EO, Boyle N, Fleming C, Coulter-Smith S, Khoo SH.

HIV Med. 2011 Mar;12(3):166-73. doi: 10.1111/j.1468-1293.2010.00865.x. Epub 2010 Aug 18.

46.

HIV testing and treatment in the antenatal care setting.

Coulter-Smith S, Lambert JS, Butler K, Brennan M, Cafferkey M.

Ir Med J. 2010 Jan;103(1):14-7.

PMID:
20222387
47.

Platelet function and HIV: a case-control study.

Satchell CS, Cotter AG, O'Connor EF, Peace AJ, Tedesco AF, Clare A, Lambert JS, Sheehan GJ, Kenny D, Mallon PW.

AIDS. 2010 Mar 13;24(5):649-57. doi: 10.1097/QAD.0b013e328336098c.

PMID:
20177361
48.

Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients.

Roe B, Coughlan S, Dean J, Lambert JS, Keating S, Norris S, Bergin C, Hall WW.

Viral Immunol. 2009 Feb;22(1):39-48. doi: 10.1089/vim.2008.0074.

PMID:
19210227
49.

Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.

Machado ES, Hofer CB, Costa TT, Nogueira SA, Oliveira RH, Abreu TF, Evangelista LA, Farias IF, Mercadante RT, Garcia MF, Neves RC, Costa VM, Lambert JS.

Sex Transm Infect. 2009 Apr;85(2):82-7. doi: 10.1136/sti.2008.032300. Epub 2008 Nov 5.

50.

Current issues in the immunoprophylaxis of vertical transmission of HIV.

Lambert JS, Moye JJ.

BioDrugs. 1999 Jan;11(1):31-41.

PMID:
18031113

Supplemental Content

Loading ...
Support Center